SCHEMBL5056983

SCHEMBL5056983

Cc1cn2nc(-c3ccccc3)cc2nc1C

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 12/20 0.54
NPC1 O15118 10/20 0.54
SMN1; SMN2 Q16637 8/20 0.54
ALDH1A1 P00352 7/20 0.54
HPGD P15428 5/20 0.54
NFKB1 P19838 2/20 0.54
NFKB2 Q00653 2/20 0.54
RELA Q04206 2/20 0.54
HTT P42858 1/20 0.54
KDM4E B2RXH2 9/20 0.53
MAPT P10636 3/20 0.51
TP53 P04637 5/20 0.49
HSD17B10 Q99714 4/20 0.49
PKM P14618 4/20 0.49
TSHR P16473 3/20 0.49
CASP1 P29466 1/20 0.49
CASP7 P55210 1/20 0.49
KMT2A Q03164 3/20 0.47
MEN1 O00255 2/20 0.47
GAA P10253 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1668742 0.83 RAB9A (0.51) RAB9ANPC1SMN1; SMN2ALDH1A1HPGD
SCHEMBL26704246 0.77 KDM4E (0.43) RAB9ANPC1SMN1; SMN2ALDH1A1HTT
SCHEMBL2749583 0.77 RAB9A (0.58) RAB9ANPC1SMN1; SMN2ALDH1A1HPGD
SCHEMBL13750723 0.72 RAB9A (0.54) RAB9ANPC1SMN1; SMN2ALDH1A1HPGD
SCHEMBL13258606 0.72 NPC1 (0.67) RAB9ANPC1SMN1; SMN2ALDH1A1HPGD
SCHEMBL1666734 0.72 NPC1 (0.48) RAB9ANPC1SMN1; SMN2ALDH1A1HPGD
SCHEMBL9106471 0.71 PDE10A (0.47) RAB9ANPC1SMN1; SMN2ALDH1A1HPGD
Hydrochloric Acid SCHEMBL9108349 0.70 PDE10A (0.46) RAB9ANPC1SMN1; SMN2ALDH1A1HPGD
SCHEMBL11386471 0.69 NPC1 (0.45) RAB9ANPC1SMN1; SMN2ALDH1A1HPGD
SCHEMBL5270613 0.69 NPC1 (1.00) RAB9ANPC1SMN1; SMN2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1912966-A2 2-OXO-1-PYRROLIDINE DERIVATIVES AND THEIR THERAPEUTIC USE ON THE CENTRAL NERVOUS SYSTEM UCB, S.A. (BE) 2008-04-23 EP claimed
EP-1891042-A2 2-OXO-1-PYRROLIDINE DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR THERAPEUTIC USE ON THE CENTRAL NERVOUS SYSTEM UCB Pharma, S.A. (BE) 2008-02-27 EP claimed
WO-2006128692-A2 2-OXO-1-PYRROLIDINE DERIVATIVES AND THEIR THERAPEUTIC USE ON THE CENTRAL NERVOUS SYSTEM UCB PHARMA, S.A. (BE) 2006-12-07 WO claimed
WO-2006128693-A2 2 -OXO-I -PYRROLIDINE DERIVATIVES/ PROCESSES FOR PREPARING THEM AND THEIR THERAPEUTIC USE ON THE CENTRAL NERVOUS SYSTEM UCB PHARMA, S.A. (BE) 2006-12-07 WO claimed
EP-1912966-A2 2-OXO-1-PYRROLIDINE DERIVATIVES AND THEIR THERAPEUTIC USE ON THE CENTRAL NERVOUS SYSTEM UCB, S.A. (BE) 2008-04-23 EP disclosed
EP-1891042-A2 2-OXO-1-PYRROLIDINE DERIVATIVES, PROCESSES FOR PREPARING THEM AND THEIR THERAPEUTIC USE ON THE CENTRAL NERVOUS SYSTEM UCB Pharma, S.A. (BE) 2008-02-27 EP disclosed
WO-2006128692-A2 2-OXO-1-PYRROLIDINE DERIVATIVES AND THEIR THERAPEUTIC USE ON THE CENTRAL NERVOUS SYSTEM UCB PHARMA, S.A. (BE) 2006-12-07 WO disclosed
WO-2006128693-A2 2 -OXO-I -PYRROLIDINE DERIVATIVES/ PROCESSES FOR PREPARING THEM AND THEIR THERAPEUTIC USE ON THE CENTRAL NERVOUS SYSTEM UCB PHARMA, S.A. (BE) 2006-12-07 WO disclosed